4 Lymphoma Clinical Trials in Mobile, AL (2026)

Q: How do I join a clinical trial in Mobile?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Mobile research site will contact you.

Recruiting Lymphoma Studies in Mobile

NCT05675410Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard treatment alone in i...

Mobile, ALPHASE31,875 participantsNational Cancer Institute (NCI)

View Study Details

NCT06717347Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

The purpose of this study is to evaluate if zilovertamab vedotin with standard treatment can help people live longer without the cancer growing or spreading than people who receive standard treatment ...

Mobile, ALPHASE31,046 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06890884Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Researchers are looking for ways to treat germinal center B-cell-like diffuse large B-cell lymphoma (GCB DLBCL). DLBCL is a fast-growing blood cancer that affects B-cells. GCB is a type of DLBCL that ...

Mobile, ALPHASE2594 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06911502Recruiting

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma (GOLSEEK-4)

The study is designed as a multicenter, randomized, open label Phase 3 study to compare the efficacy and safety of golcadomide in combination with rituximab vs investigator's choice in participants wi...

Mobile, ALPHASE3400 participantsCelgene

View Study Details

About Lymphoma Clinical Trials in Mobile

Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.

There are currently 4 lymphoma clinical trials recruiting participants in Mobile, AL. These studies are seeking a combined 3,915 participants. Research is being sponsored by National Cancer Institute (NCI), Merck Sharp & Dohme LLC, Celgene. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lymphoma Clinical Trials in Mobile — FAQ

Are there lymphoma clinical trials in Mobile?

Yes, there are 4 lymphoma clinical trials currently recruiting in Mobile, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Mobile?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mobile research site will contact you about next steps.

Are clinical trials in Mobile free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mobile studies also compensate for your time and travel.

What lymphoma treatments are being tested?

The 4 active trials in Mobile are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.

Data updated July 20, 2026 from ClinicalTrials.gov